共 50 条
- [3] Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis Israel Journal of Health Policy Research, 7
- [4] Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? - a cost-utility analysis ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2018, 7
- [7] Impfung gegen das „respiratory syncytial virus“Vaccination against respiratory syncytial virus Die Innere Medizin, 2023, 64 : 907 - 910